Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRACE-AFib
NCT07904507Phase 4Not yet recruiting
- Sponsor
- University Hospital Basel
- Start
- Nov 2026
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
A Phase 4 trial of diltiazem in Atrial fibrillation (AFib), sponsored by University Hospital Basel. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
diltiazem
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07904507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07904507.